Actionable news
All posts from Actionable news
Actionable news in ZIOP: ZIOPHARM Oncology Inc,

Ziopharm Oncology (ZIOP) Stock Advances After Q2 Results, Upgrade

NEW YORK (TheStreet) -- Shares of Ziopharm Oncology (ZIOP) were rising 8.64% to $5.28 on heavy trading volume mid-afternoon Wednesday after the company posted a narrower-than-anticipated loss for the 2016 second quarter.

After yesterday's market close, the Boston-based biopharmaceutical company posted an adjusted loss of 10 cents per share, the Associated Press reported. Analysts were expecting a loss of 11 cents per share.

Revenue for the quarter was $1.7 million, higher than Wall Street's estimates of $1.5...